ADMP Adamis Pharmaceuticals Corp

Adamis Pharmaceuticals Corp is a specialty biopharmaceutical company that develops & commercializes products in the therapeutic areas of respiratory disease & allergy. Its products include Epinephrine Injection PFS syringe, APC-1000, APC-2000, & APC-5000.

$0.50
As of 07/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  01/02/2003
Outstanding shares:  149,733,265
Average volume:  504,212
Market cap:   $75,016,366
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -1.98
PB ratio:   4.72
PS ratio:   7.06
Return on equity:   -111.90%
Net income %:   -167.50%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy